RS58423B1 - Upotreba tiazolo pirimidinona za lečenje inflamatorne bolesti creva - Google Patents
Upotreba tiazolo pirimidinona za lečenje inflamatorne bolesti crevaInfo
- Publication number
- RS58423B1 RS58423B1 RS20190216A RSP20190216A RS58423B1 RS 58423 B1 RS58423 B1 RS 58423B1 RS 20190216 A RS20190216 A RS 20190216A RS P20190216 A RSP20190216 A RS P20190216A RS 58423 B1 RS58423 B1 RS 58423B1
- Authority
- RS
- Serbia
- Prior art keywords
- compound
- treatment
- dose
- pharmaceutical preparation
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1718MU2013 | 2013-05-14 | ||
| IN2309MU2013 | 2013-07-09 | ||
| PCT/IB2014/000707 WO2014184631A1 (en) | 2013-05-14 | 2014-05-12 | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease |
| EP14728622.3A EP2996693B1 (en) | 2013-05-14 | 2014-05-12 | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS58423B1 true RS58423B1 (sr) | 2019-04-30 |
Family
ID=50896342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20190216A RS58423B1 (sr) | 2013-05-14 | 2014-05-12 | Upotreba tiazolo pirimidinona za lečenje inflamatorne bolesti creva |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US9610247B2 (https=) |
| EP (1) | EP2996693B1 (https=) |
| JP (1) | JP6407974B2 (https=) |
| KR (1) | KR102239649B1 (https=) |
| CN (1) | CN105209043B (https=) |
| AU (1) | AU2014266968B2 (https=) |
| BR (1) | BR112015028581B1 (https=) |
| CA (1) | CA2912011C (https=) |
| CY (1) | CY1121280T1 (https=) |
| DK (1) | DK2996693T3 (https=) |
| EA (1) | EA030590B1 (https=) |
| ES (1) | ES2712705T3 (https=) |
| HR (1) | HRP20190315T1 (https=) |
| HU (1) | HUE042691T2 (https=) |
| IL (1) | IL242490B (https=) |
| LT (1) | LT2996693T (https=) |
| MX (1) | MX358198B (https=) |
| MY (1) | MY179215A (https=) |
| PH (1) | PH12015502560B1 (https=) |
| PL (1) | PL2996693T3 (https=) |
| PT (1) | PT2996693T (https=) |
| RS (1) | RS58423B1 (https=) |
| SG (1) | SG11201509275PA (https=) |
| SI (1) | SI2996693T1 (https=) |
| SM (1) | SMT201900111T1 (https=) |
| TW (1) | TWI661828B (https=) |
| UA (1) | UA117244C2 (https=) |
| WO (1) | WO2014184631A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11324829B2 (en) * | 2016-03-14 | 2022-05-10 | Santen Pharmaceutical Co., Ltd. | Antiseptic agent comprising meglumine or salt thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8962530B2 (en) * | 2007-06-27 | 2015-02-24 | Regents Of The University Of Colorado | Inflammatory bowel disease therapies |
| TWI500623B (zh) * | 2009-10-13 | 2015-09-21 | Torrent Pharmaceuticals Ltd | 新穎稠合噻唑及噁唑嘧啶酮 |
| US8541430B2 (en) * | 2009-11-27 | 2013-09-24 | Torrent Pharmaceuticals Limited | Fused thiazolo and oxazolo pyrimidinones |
-
2014
- 2014-05-09 TW TW103116529A patent/TWI661828B/zh not_active IP Right Cessation
- 2014-05-12 SM SM20190111T patent/SMT201900111T1/it unknown
- 2014-05-12 HR HRP20190315TT patent/HRP20190315T1/hr unknown
- 2014-05-12 CN CN201480028313.6A patent/CN105209043B/zh not_active Expired - Fee Related
- 2014-05-12 DK DK14728622.3T patent/DK2996693T3/en active
- 2014-05-12 AU AU2014266968A patent/AU2014266968B2/en not_active Ceased
- 2014-05-12 RS RS20190216A patent/RS58423B1/sr unknown
- 2014-05-12 ES ES14728622T patent/ES2712705T3/es active Active
- 2014-05-12 UA UAA201512299A patent/UA117244C2/uk unknown
- 2014-05-12 LT LTEP14728622.3T patent/LT2996693T/lt unknown
- 2014-05-12 US US14/890,131 patent/US9610247B2/en not_active Expired - Fee Related
- 2014-05-12 CA CA2912011A patent/CA2912011C/en active Active
- 2014-05-12 EA EA201592159A patent/EA030590B1/ru not_active IP Right Cessation
- 2014-05-12 JP JP2016513452A patent/JP6407974B2/ja not_active Expired - Fee Related
- 2014-05-12 PL PL14728622T patent/PL2996693T3/pl unknown
- 2014-05-12 MX MX2015015682A patent/MX358198B/es active IP Right Grant
- 2014-05-12 SI SI201431085T patent/SI2996693T1/sl unknown
- 2014-05-12 SG SG11201509275PA patent/SG11201509275PA/en unknown
- 2014-05-12 WO PCT/IB2014/000707 patent/WO2014184631A1/en not_active Ceased
- 2014-05-12 KR KR1020157033744A patent/KR102239649B1/ko not_active Expired - Fee Related
- 2014-05-12 HU HUE14728622A patent/HUE042691T2/hu unknown
- 2014-05-12 EP EP14728622.3A patent/EP2996693B1/en active Active
- 2014-05-12 MY MYPI2015704098A patent/MY179215A/en unknown
- 2014-05-12 BR BR112015028581-3A patent/BR112015028581B1/pt not_active IP Right Cessation
- 2014-05-12 PT PT14728622T patent/PT2996693T/pt unknown
-
2015
- 2015-11-08 IL IL242490A patent/IL242490B/en active IP Right Grant
- 2015-11-10 PH PH12015502560A patent/PH12015502560B1/en unknown
-
2017
- 2017-02-22 US US15/439,733 patent/US10471005B2/en not_active Expired - Fee Related
-
2019
- 2019-02-21 CY CY20191100221T patent/CY1121280T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200000726A1 (en) | Gastroresistant pharmaceutical formulations containing rifaximin | |
| JP6796132B2 (ja) | 液体剤形中の薬学的活性化合物放出性多層微小粒子 | |
| WO2009047801A1 (en) | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders | |
| JP6566638B2 (ja) | メサラミンの放出制御固形製剤 | |
| KR102381586B1 (ko) | 메살라진의 경구용 약제학적 조성물 | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| JP2022093472A (ja) | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 | |
| TW201739455A (zh) | 菸鹼醯胺的口服醫藥組成物 | |
| US10471005B2 (en) | Low dose pharmaceutical composition | |
| NZ714098B2 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease |